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Lichen planus (LP) is a common chronic inﬂammatory mucocu-
taneous condition of unknown origin that usually affects middle-
aged patients. Nail involvement occurs in 10% of patients, with per-
manent damage to at least one nail occurring in ~4% of patients. The
nails may also be affected in the absence of cutaneous symptoms.1
Hereinwe report a case of a patient with nail LP whowas refractory
to topical and intralesional corticosteroids but was treated success-
fully with topical tacrolimus.
A 17-year-old girl was referred from a local clinic for onychodys-
trophy of ﬁngernails with poor response to topical agents. The nail
lesions had occurred and progressed for 2 months. The patient de-
nied any trauma to, or contact history for, the affected areas.Figure 1 Patient with nail lichen planus. (A) Asymptomatic slightly raised whitish linear lin
hand involvement; (C) nail deformity of left index ﬁnger; and (D) nail deformity of left rin
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including swelling with erythematous change without cutical
involvement of the proximal nail folds and onycholysis, on the sec-
ond and forth ﬁngers of the left hand and the ﬁfth ﬁnger of the right
hand. Asymptomatic slightly raised whitish plaques were noted
over the bilateral buccal mucosa (Figure 1). No other skin lesions
were found. A nail matrix biopsy was suggested, but the patient
refused due to concerns over possible nail deformity after the bi-
opsy. Some recent studies have suggested that a diagnosis of nail
LP may be made when it exists together with typical cutaneous/
mucous membrane disease.2 Under the clinical impression of nail
and oral lichen planus, twice daily treatment with topical triamcin-
olone ointment for the oral lesions and twice daily topical treat-
ment with 0.1% diﬂucortolone valerate ointment along withes in a lace-like pattern and whitish plaques over bilateral buccal mucosa; (B) bilateral
g ﬁnger.
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Figure 2 Nail lichen planus treatment. (A) After 2 weeks of topical triamcinolone ointment twice a day treatment, buccal lesions resolved; (B) 4 months after topical tacrolimus
treatment; (C) left index ﬁnger; and (D) left ring ﬁnger.
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sions were initiated. After 2 weeks of therapy, the buccal lesions
resolved (Figure 2A). However, onychodystrophy of the ﬁngernails
persisted after 2 months of topical and intralesional corticosteroid
treatment. Therefore, treatment with topical and intralesional cor-
ticosteroids were both held and topical 0.1% tacrolimus ointment
was then tried on the proximal and lateral nail folds twice a day.
The nail lesions began to improve after 2 weeks of treatment and
showed marked improvement 4 months after topical tacrolimus
treatment (Figure 2). Thus far, the patient has exhibited no signs
of relapsing.
Although mild nail LP is usually asymptomatic, deformation of
the nails often causes depression among patients. Nail loss or per-
manent nail dystrophy may even occur in some cases.3 Treatment
of nail LP is difﬁcult, and an optimal therapy is confusing. Different
treatment modalities have been used in nail LP. Although they are
usually ineffective, topical corticosteroids are commonly consid-
ered as a ﬁrst-line treatment for nail LP. For involvement of up to
three nails, intralesional steroid injections can be considered, but
such injections are very painful and relapses are common.2 If
more than three nails are involved, systemic corticosteroids are
considered as a ﬁrst-line treatment; however, prolonged or
repeated use of systemic corticosteroids may cause considerable
side effects.4 To the best of our knowledge, there has only been a
single previously published case report in English regarding the
successful use of tacrolimus ointment to treat nail LP.3 Activated
T cells are likely to play an important role in the pathogenesis of
LP, and tacrolimus is an immunosuppressive agent which has
been shown to be 10e100 times more potent than cyclosporine
in the inhibition of T-cell activation.5 Topical tacrolimus has been
reported as a safe, effective therapy for cutaneous,6 oral,7 and
vulvar LP,8 even in patients whose lesions have shown recalcitrance
to other treatments. In a previous report regarding topical tacroli-
mus treatment of nail LP, no recurrence after discontinuing treat-
ment was noted in two patients at 16 months and 36 months of
follow-up, respectively.3 Herein, we share an interesting case of
nail LP with a good response to treatment with topical 0.1% tacro-
limus ointment. Topical tacrolimus ointment can be an effectivetherapy for nail LP and further investigation is required to establish
the effectiveness and the long-term prognosis after the cessation of
topical tacrolimus treatment.
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